| scholarly article | Q13442814 |
| P50 | author | Jozsef Gal | Q57653594 |
| Wang-Xia Wang | Q84077281 | ||
| Peter T Nelson | Q90936675 | ||
| David W Fardo | Q57014856 | ||
| P2093 | author name string | Jing Chen | |
| Haining Zhu | |||
| Yuriko Katsumata | |||
| Ela Patel | |||
| Douglas Price | |||
| Sergey Artiushin | |||
| Sonya Anderson | |||
| P2860 | cites work | DNA-PK Deficiency in Alzheimer's Disease | Q64389910 |
| Phosphorylation of native and truncated isoforms of protein tau by the double-stranded DNA-dependent protein kinase (DNA-PK) shows that the primary phosphorylation sites are localized between amino acid residues 212-231 of the longest tau | Q71715361 | ||
| Damage to nuclear DNA in Lewy body disease | Q74425291 | ||
| Co-aggregation of RNA binding proteins in ALS spinal motor neurons: evidence of a common pathogenic mechanism | Q84918163 | ||
| Cowchock syndrome is associated with a mutation in apoptosis-inducing factor | Q24305311 | ||
| Unraveling of the E-helices and disruption of 4-fold pores are associated with iron mishandling in a mutant ferritin causing neurodegeneration | Q24318488 | ||
| Mutations in NNT encoding nicotinamide nucleotide transhydrogenase cause familial glucocorticoid deficiency | Q24336804 | ||
| Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease | Q24612662 | ||
| Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease | Q24628685 | ||
| Ferritin for the clinician | Q24642942 | ||
| PLINK: a tool set for whole-genome association and population-based linkage analyses | Q24677407 | ||
| Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease | Q26996741 | ||
| The DNA-dependent protein kinase: A multifunctional protein kinase with roles in DNA double strand break repair and mitosis | Q28081821 | ||
| Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis | Q28131672 | ||
| Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis | Q28236796 | ||
| Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6 | Q28236805 | ||
| Altered functional protein networks in the prefrontal cortex and amygdala of victims of suicide | Q28485508 | ||
| Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein | Q29547803 | ||
| Mutations of optineurin in amyotrophic lateral sclerosis | Q29614836 | ||
| Postmortem proteomic analysis in human amygdala of drug addicts: possible impact of tubulin on drug-abusing behavior. | Q33649889 | ||
| Severe X-linked mitochondrial encephalomyopathy associated with a mutation in apoptosis-inducing factor | Q33772997 | ||
| Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons | Q33828911 | ||
| DNA-PK and P38 MAPK: A Kinase Collusion in Alzheimer's Disease? | Q33892330 | ||
| Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta | Q34009618 | ||
| Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease | Q34083035 | ||
| A neuronal antigen in the brains of Alzheimer patients | Q34165422 | ||
| Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. | Q34320792 | ||
| Genome-wide analysis of genetic loci associated with Alzheimer disease | Q34339530 | ||
| A survey of human brain transcriptome diversity at the single cell level | Q34480096 | ||
| Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity | Q34554590 | ||
| Self-assembled FUS binds active chromatin and regulates gene transcription. | Q34752975 | ||
| Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death? | Q34997191 | ||
| Applying mass spectrometry-based qualitative proteomics to human amygdaloid complex. | Q35136493 | ||
| Differential clinicopathologic and genetic features of late-onset amnestic dementias | Q35545502 | ||
| Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies | Q35607253 | ||
| Disease-related microglia heterogeneity in the hippocampus of Alzheimer's disease, dementia with Lewy bodies, and hippocampal sclerosis of aging | Q35809944 | ||
| Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer's disease. | Q35917235 | ||
| Quantitative analysis of the detergent-insoluble brain proteome in frontotemporal lobar degeneration using SILAC internal standards | Q35975425 | ||
| Brain pathologies in extreme old age. | Q36395714 | ||
| Higher Prevalence of TDP-43 Proteinopathy in Cognitively Normal Asians: A Clinicopathological Study on a Multiethnic Sample | Q36573060 | ||
| Proteins that mediate protein aggregation and cytotoxicity distinguish Alzheimer's hippocampus from normal controls. | Q37235572 | ||
| Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease | Q37442587 | ||
| TDP-43 pathology and memory impairment in elders without pathologic diagnoses of AD or FTLD. | Q38382398 | ||
| "New Old Pathologies": AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS). | Q38841003 | ||
| Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi | Q38915426 | ||
| Pathology of Neurodegenerative Diseases | Q39071493 | ||
| TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia | Q39331146 | ||
| DNA end joining activity is reduced in Alzheimer's disease | Q40419228 | ||
| Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS. | Q41633788 | ||
| Pathological alterations in the amygdala in Alzheimer's disease | Q41767135 | ||
| Amygdala cell loss and atrophy in Alzheimer's disease | Q42457217 | ||
| Volumetric atrophy of the amygdala in Alzheimer's disease: quantitative serial reconstruction | Q42475799 | ||
| Amygdala pathology in Parkinson's disease | Q42489917 | ||
| TDP-43 pathology in the population: prevalence and associations with dementia and age. | Q44767912 | ||
| Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression | Q44921042 | ||
| A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice | Q45281560 | ||
| Population variation in oxidative stress and astrocyte DNA damage in relation to Alzheimer-type pathology in the ageing brain. | Q46021843 | ||
| Is DNA repair compromised in Alzheimer's disease? | Q46444487 | ||
| NNT mutations: a cause of primary adrenal insufficiency, oxidative stress and extra-adrenal defects. | Q46555872 | ||
| Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights | Q47813038 | ||
| Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology | Q47861971 | ||
| Mixed brain pathologies account for most dementia cases in community-dwelling older persons | Q48136681 | ||
| Alzheimer neuropathologic alterations in aged cognitively normal subjects | Q48226793 | ||
| Brain donation in normal aging: procedures, motivations, and donor characteristics from the Biologically Resilient Adults in Neurological Studies (BRAiNS) Project | Q48656039 | ||
| The amygdala in Alzheimer's disease: Neuropathology and Alz 50 Immunoreactivity | Q48662549 | ||
| Neuropathological study of the amygdala in presenile Alzheimer's disease | Q48851832 | ||
| TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype | Q48864196 | ||
| Disentangling a complex pattern of interrelationships among multiple measures of Alzheimer neuropathology and clinical status: comments on Cummings, Pike, Shankle, and Cotman | Q48865821 | ||
| Updated TDP-43 in Alzheimer's disease staging scheme | Q48949710 | ||
| Multiregional Age-Associated Reduction of Brain Neuronal Reserve Without Association With Neurofibrillary Degeneration or β-Amyloidosis | Q50438030 | ||
| Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. | Q52011735 | ||
| Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun study. | Q52030230 | ||
| Lewy body and Alzheimer pathology in a family with the amyloid-beta precursor protein APP717 gene mutation. | Q53237338 | ||
| Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies. | Q53299106 | ||
| Alpha-synuclein in familial Alzheimer disease: epitope mapping parallels dementia with Lewy bodies and Parkinson disease. | Q53349523 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 21-39 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Journal of Neuropathology & Experimental Neurology | Q15716771 |
| P1476 | title | Detergent Insoluble Proteins and Inclusion Body-Like Structures Immunoreactive for PRKDC/DNA-PK/DNA-PKcs, FTL, NNT, and AIFM1 in the Amygdala of Cognitively Impaired Elderly Persons | |
| P478 | volume | 77 |
Search more.